Literature DB >> 30104744

The complex aetiology of cerebral palsy.

Steven J Korzeniewski1, Jaime Slaughter2, Madeleine Lenski3, Peterson Haak4, Nigel Paneth3,5.   

Abstract

Cerebral palsy (CP) is the most prevalent, severe and costly motor disability of childhood. Consequently, CP is a public health priority for prevention, but its aetiology has proved complex. In this Review, we summarize the evidence for a decline in the birth prevalence of CP in some high-income nations, describe the epidemiological evidence for risk factors, such as preterm delivery and fetal growth restriction, genetics, pregnancy infection and other exposures, and discuss the success achieved so far in prevention through the use of magnesium sulfate in preterm labour and therapeutic hypothermia for birth-asphyxiated infants. We also consider the complexities of disentangling prenatal and perinatal influences, and of establishing subtypes of the disorder, with a view to accelerating the translation of evidence into the development of strategies for the prevention of CP.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30104744     DOI: 10.1038/s41582-018-0043-6

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  32 in total

1.  Molecular Diagnostic Yield of Exome Sequencing in Patients With Cerebral Palsy.

Authors:  Andrés Moreno-De-Luca; Francisca Millan; Denis R Pesacreta; Houda Z Elloumi; Matthew T Oetjens; Claire Teigen; Karen E Wain; Julie Scuffins; Scott M Myers; Rebecca I Torene; Vladimir G Gainullin; Kevin Arvai; H Lester Kirchner; David H Ledbetter; Kyle Retterer; Christa L Martin
Journal:  JAMA       Date:  2021-02-02       Impact factor: 56.272

Review 2.  Dysregulation of multiple signaling pathways: A possible cause of cerebral palsy.

Authors:  Jyoti Upadhyay; Mohd Nazam Ansari; Abdul Samad; Ashutosh Sayana
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-07

Review 3.  Progress in clinical trials of stem cell therapy for cerebral palsy.

Authors:  Zhong-Yue Lv; Ying Li; Jing Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

4.  Altered cytokine responses in children with cerebral palsy: pathogenesis and novel therapies.

Authors:  Mark R Schleiss
Journal:  Dev Med Child Neurol       Date:  2021-02-02       Impact factor: 4.864

5.  Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Glob Health       Date:  2018-08-29       Impact factor: 38.927

6.  Metabolomic Profiling of Cerebral Palsy Brain Tissue Reveals Novel Central Biomarkers and Biochemical Pathways Associated with the Disease: A Pilot Study.

Authors:  Zeynep Alpay Savasan; Ali Yilmaz; Zafer Ugur; Buket Aydas; Ray O Bahado-Singh; Stewart F Graham
Journal:  Metabolites       Date:  2019-02-02

Review 7.  Role of child neurologists and neurodevelopmentalists in the diagnosis of cerebral palsy: A survey study.

Authors:  Bhooma R Aravamuthan; Michael Shevell; Young-Min Kim; Jenny L Wilson; Jennifer A O'Malley; Toni S Pearson; Michael C Kruer; Michael Fahey; Jeff L Waugh; Barry Russman; Bruce Shapiro; Ann Tilton
Journal:  Neurology       Date:  2020-10-12       Impact factor: 9.910

Review 8.  Cerebral palsy in children born after assisted reproductive technology: a meta-analysis.

Authors:  Fang-Fang Wang; Tao Yu; Xiao-Lu Chen; Rong Luo; De-Zhi Mu
Journal:  World J Pediatr       Date:  2021-07-20       Impact factor: 2.764

9.  Associations Between Subclass Profile of IgG Response to Gluten and the Gastrointestinal and Motor Symptoms in Children With Cerebral Palsy.

Authors:  Reidun Stenberg; Melanie Uhde; Mary Ajamian; Peter H Green; Anna Myleus; Armin Alaedini
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-09-01       Impact factor: 3.288

10.  Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.

Authors:  Sheng Chih Jin; Sara A Lewis; Somayeh Bakhtiari; Xue Zeng; Michael C Sierant; Sheetal Shetty; Sandra M Nordlie; Aureliane Elie; Mark A Corbett; Bethany Y Norton; Clare L van Eyk; Shozeb Haider; Brandon S Guida; Helen Magee; James Liu; Stephen Pastore; John B Vincent; Janice Brunstrom-Hernandez; Antigone Papavasileiou; Michael C Fahey; Jesia G Berry; Kelly Harper; Chongchen Zhou; Junhui Zhang; Boyang Li; Hongyu Zhao; Jennifer Heim; Dani L Webber; Mahalia S B Frank; Lei Xia; Yiran Xu; Dengna Zhu; Bohao Zhang; Amar H Sheth; James R Knight; Christopher Castaldi; Irina R Tikhonova; Francesc López-Giráldez; Boris Keren; Sandra Whalen; Julien Buratti; Diane Doummar; Megan Cho; Kyle Retterer; Francisca Millan; Yangong Wang; Jeff L Waugh; Lance Rodan; Julie S Cohen; Ali Fatemi; Angela E Lin; John P Phillips; Timothy Feyma; Suzanna C MacLennan; Spencer Vaughan; Kylie E Crompton; Susan M Reid; Dinah S Reddihough; Qing Shang; Chao Gao; Iona Novak; Nadia Badawi; Yana A Wilson; Sarah J McIntyre; Shrikant M Mane; Xiaoyang Wang; David J Amor; Daniela C Zarnescu; Qiongshi Lu; Qinghe Xing; Changlian Zhu; Kaya Bilguvar; Sergio Padilla-Lopez; Richard P Lifton; Jozef Gecz; Alastair H MacLennan; Michael C Kruer
Journal:  Nat Genet       Date:  2020-09-28       Impact factor: 41.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.